Anumana Named to Fast Company’s 2026 Most Innovative Companies Awards

Recognition highlights Anumana’s leadership in AI-driven cardiovascular detection and clinical decision support

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in AI-powered cardiovascular detection algorithms, today announced it has been named to Fast Company’s prestigious 2026 Most Innovative Companies list in the Medical Devices category. The annual award recognizes hardware and technologies changing how healthcare is delivered and celebrates organizations that are shaping industries through impactful innovation and real-world progress.

Anumana was selected for developing AI-enabled detection algorithms that uncover hidden cardiovascular disease from routine electrocardiograms (ECGs) and for designing solutions that translate those insights into tools that support clinical decision-making at the point of care.

“We’re honored to be recognized by Fast Company and see it as a reflection of the growing role AI will play in transforming how cardiovascular disease is identified and treated,” said Maulik Nanavaty, CEO of Anumana. “At Anumana, we’re focused on helping clinicians detect earlier signals of risk from routine ECG data and turning that information into clinically validated tools that can be used in everyday care to help support better patient outcomes.”

Over the past year, Anumana advanced a portfolio of FDA-cleared and investigational ECG-AI™ software-as-a-medical-device (SaMD) solutions designed to detect early signs of cardiovascular disease using standard 12-lead ECG data. Medicare reimbursement for the company’s ECG-AI LEF (low ejection fraction) algorithm, effective January 2025, marked the first approved payment for an AI-enabled ECG technology designed to identify heart failure risk during routine care.

Building on this foundation, Anumana is expanding its ECG-AI portfolio across structural heart disease, interventional cardiology, and electrophysiology, while increasing access through integrations with leading ECG manufacturers and collaborations with major academic medical centers. The company is also advancing an intraprocedural platform that uses multimodal data and generative AI to deliver real-time insights during complex cardiac procedures.

Supporting this continued innovation is a growing body of clinical and scientific evidence. Over the past year, 19 new peer-reviewed studies have been published, supporting the science behind Anumana’s ECG-AI platform, bringing the total to more than 100 publications. The company also strengthened its intellectual property portfolio with over 300 patents, including 116 granted, reinforcing the clinical and scientific foundation behind its AI innovations.

The World’s Most Innovative Companies list is Fast Company’s hallmark franchise and one of its most anticipated editorial efforts of the year. To determine honorees, Fast Company’s editors and writers review companies driving progress around the world and across industries, evaluating thousands of submissions through a competitive application process. The result is a globe-spanning guide to innovation today, from early-stage startups to some of the most valuable companies in the world.

“Our list of the Most Innovative Companies is about spotlighting organizations that don’t just adapt to change—they drive it,” said Brendan Vaughan, editor-in-chief of Fast Company. “The companies we honor this year are redefining what leadership looks like in 2026, pairing bold ideas with measurable impact and turning breakthrough innovation into real-world value. They are setting the pace for their industries and offering a blueprint for what sustained innovation can achieve.”

The full list of Fast Company’s Most Innovative Companies honorees can now be found at fastcompany.com. It will also be available on newsstands beginning March 31, 2026.

About Anumana

Anumana is an AI-driven health technology company committed to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana is developing software-as-a-medical-device (SaMD) solutions that apply multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes ECG-based algorithms, generative imaging applications, and real-time procedural support tools designed to improve outcomes in both diagnostic and intraprocedural settings. The company’s FDA-cleared ECG-AI™ LEF algorithm is currently available in the U.S. and eligible for reimbursement as of January 2025. Please visit www.anumana.ai for more information and follow Anumana on LinkedIn for company updates.

About Fast Company

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with fellow business publication Inc. For more information, please visit fastcompany.com.

Anumana Media Contact
Andrea Sampson
President/CEO, Sampson Public Relations Group
asampson@sampsonprgroup.com